Mereo BioPharma Group PLC ADR (MREO) earnings · $48.7M cap
Mereo BioPharma Group PLC ADR (MREO) is a biotechnology company listed on US.
This MREO earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported MREO revenue for 2026-06-30 was $0. Net income was -$7.0M. Revenue was down 100.0% from 2026-03-31 to 2026-06-30. MREO currently screens at market cap $48.7M.
When the next MREO 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 100.0% from 2026-03-31 to 2026-06-30. An earnings headline that ignores that move is noise.
Not investment advice. Full MREO research stays on the stock page; the tape stays on the quote page.
Not investment advice.